Platelet transfusion therapy against chronic hepatitis and liver cirrhosis
Phase 1
- Conditions
- chronic hepatitis liver cirrhosis
- Registration Number
- JPRN-UMIN000001164
- Lead Sponsor
- niversity of Tsukuba
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1)platelet count was less than 50 thousand/microlitter in the latest data 2)past history of shock on platelet transfusion 3)bone marrow transplantation(exept auto-transplantation) recipient or immunosuprrsive patients 4)IgA deficiency or other plasma protein deficiency 5)women with pregnancy, lactation or willing to get pregnant
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method fibrosis markers: type IV collagen, hyarulonic acid, PIIIP liver function: albumin, AST, ALT, bilirubin, prothrombin time
- Secondary Outcome Measures
Name Time Method abdominal ultrasonography and CT platelet count anti-platelet antibody amount of hepatitis virus